These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 19008178

  • 1. Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma.
    Wasmuth JC, Fischer HP, Sauerbruch T, Dumoulin FL.
    Eur J Med Res; 2008 Oct 27; 13(10):483-6. PubMed ID: 19008178
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B.
    Haematologica; 2003 Nov 27; 88(11):1296-303. PubMed ID: 14607759
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.
    J Clin Oncol; 2009 Feb 01; 27(4):605-11. PubMed ID: 19075267
    [Abstract] [Full Text] [Related]

  • 4. Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.
    Stange MA, Tutarel O, Pischke S, Schneider A, Strassburg CP, Becker T, Barg-Hock H, Bastürk M, Wursthorn K, Cornberg M, Ott M, Greten TF, Manns MP, Wedemeyer H.
    Z Gastroenterol; 2010 Feb 01; 48(2):258-63. PubMed ID: 20127601
    [Abstract] [Full Text] [Related]

  • 5. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.
    Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Kanamori H, Obara S, Asaka M, Imamura M, Masauzi N.
    Ann Hematol; 2004 Jan 01; 83(1):58-60. PubMed ID: 14513286
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma.
    Stroffolini T, Andriani A, Bibas M, Barlattani A.
    Ann Hematol; 2002 Jan 01; 81(1):48-9. PubMed ID: 11807636
    [Abstract] [Full Text] [Related]

  • 7. [Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].
    Muñoz Bertrán E, Pérez Ceballos E, Gómez Espín R, Ortega González I.
    Gastroenterol Hepatol; 2010 May 01; 33(5):377-81. PubMed ID: 20363054
    [Abstract] [Full Text] [Related]

  • 8. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H, Cai Q, Lin T, Lin X, Liu Y, Gao Y, Peng R.
    Expert Opin Pharmacother; 2009 Oct 01; 10(15):2399-406. PubMed ID: 19761353
    [Abstract] [Full Text] [Related]

  • 9. Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
    Dillon R, Hirschfield GM, Allison ME, Rege KP.
    BMJ; 2008 Jul 01; 337():a423. PubMed ID: 18595895
    [No Abstract] [Full Text] [Related]

  • 10. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM, Huang YH, Lee PC, Lin HC, Lee SD.
    J Clin Gastroenterol; 2009 Jul 01; 43(5):496-8. PubMed ID: 19247200
    [Abstract] [Full Text] [Related]

  • 11. [Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].
    van der Eijk AA, Doorduijn JK, Janssen HL, Schalm SW, Niesters HG, de Man RA.
    Ned Tijdschr Geneeskd; 2002 Jun 15; 146(24):1140-4. PubMed ID: 12092307
    [Abstract] [Full Text] [Related]

  • 12. Reactivation of hepatitis B virus with rituximab.
    Tsutsumi Y, Kanamori H, Mori A, Tanaka J, Asaka M, Imamura M, Masauzi N.
    Expert Opin Drug Saf; 2005 May 15; 4(3):599-608. PubMed ID: 15934864
    [Abstract] [Full Text] [Related]

  • 13. Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.
    Tam C, Seymour JF, Brown M, Campbell P, Scarlett J, Underhill C, Ritchie D, Bond R, Grigg AP.
    Haematologica; 2005 May 15; 90(5):700-2. PubMed ID: 15921393
    [Abstract] [Full Text] [Related]

  • 14. Acute liver failure related to chemotherapy.
    Wijaya I, Sanityoso A, Lesmana LA.
    Acta Med Indones; 2012 Apr 15; 44(2):145-9. PubMed ID: 22745146
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reactivation of hepatitis B.
    Hoofnagle JH.
    Hepatology; 2009 May 15; 49(5 Suppl):S156-65. PubMed ID: 19399803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.